Company Description
Valeant Pharmaceuticals is in the anti-virus business, but don't look for its products in the software aisle. The firm makes about 370 prescription...
Key Valeant Financials
| Company Type | Public - NYSE: VRX Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $872.2 |
| 2007 Employees | 3,301 |
More Valeant Financials (11 pages)
Latest Valeant Jobs jobs by Indeed
Rankings
- S&P 400
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Valeant's competition across multiple industries
Top Valeant Competitors
Sponsored Links
The Business Directory
Valeant Executives
| Title | Name & Bio | Contact |
|---|---|---|
| EVP Human Resources and General Counsel | Eileen C. Pruette | Network | E-mail |
| SVP and CFO | Peter J. Blott | Network | E-mail |
| Chairman and CEO | J. Michael (Mike) Pearson | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Valeant News
- Valeant Pharmaceuticals International (VRX) Corporate Event Announcement Notice [Wall Street Horizon] (01 Oct 2008 21:33:00 EDT)
- GETTING THERE: Electric scooter really scoots [Gazette (Colorado Springs, CO)] (26 Sep 2008 04:00:00 EDT)
- Valeant Pharmaceuticals International (VRX) Corporate Event Announcement Notice [Wall Street Horizon] (23 Sep 2008 21:31:00 EDT)
Sponsored Opportunity
